AAPL, CDTX, QBTS, ASELS: Market End-of-Day Evaluation

Market Developments

The end-of-day assessment in the stock markets is particularly shaped by significant developments in the technology and biotechnology sectors. Apple's (AAPL) launch of the iPhone 17 series in China has resulted in a 22% increase in the company's sales. In the first month following the launch, the iPhone 17 accounted for four-fifths of smartphone sales in China, marking a remarkable success.

Merck and Cidara Agreement

On the other hand, Merck (MRK) is approaching a significant acquisition agreement with the biotechnology firm Cidara Therapeutics (CDTX). According to reports from The Financial Times, this agreement is expected to include a price above Cidara's market value of approximately $3.3 billion. This situation is seen as a step that will support Merck's strategic expansion in the biotechnology field.

D-Wave and CEO Sale

The large-scale sale of shares by D-Wave Quantum (QBTS) CEO Alan E. Baratz has drawn attention in the markets. Baratz sold a total of 806,288 shares for $23.2 million on November 11. This situation may create uncertainty among investors.

ASELS and KARSN's Export Agreements

Aselsan (ASELS) has taken a significant step in the defense industry by signing export contracts worth a total of 153.8 million TL. In addition, Karsan (KARSN) has signed a comprehensive agreement with the Municipality of Timișoara in Romania to sell 30 units of the 10-meter e-ATA vehicles, 30 slow charging stations, and 15 pantograph charging stations for approximately 17 million euros.

Hat-San Ship's Investment Project

Hat-San Ship (HATSN) has announced the successful completion of the construction of its floating dock investment project. These developments are seen as a significant milestone for the company's future projections.

It will be beneficial for investors to consider this information in their strategic decision-making processes. However, it should be noted that the information here does not constitute investment advice.